House Armed Services Committee Calls for Update on DNA Marking as Counterfeit Prevention

Applied DNA Sciences announced that a report on the use of DNA marking on microelectronics was included in legislative language in the National Defense Authorization Act for Fiscal Year 2015 by the U.S. House of Representatives Armed Services Committee (HASC). The language provides further that the Department of Defense will evaluate expanding anti-counterfeit measures to additional classes of technology deemed high risk.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
"We are proud to contribute to DoD’s efforts to exclude counterfeits from their supply chain. Counterfeit electronics risk cybersecurity, the safety of our war fighters and the reliability of their equipment."

STONY BROOK, NY (PRWEB) May 12, 2014

May 12, 2014. Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a biotechnology firm that provides DNA-based authentication and security solutions and services, announced today that the U.S. House of Representatives Armed Services Committee (HASC) included legislative language directing the Department of Defense to provide the Committee with an assessment of the Department of Defense counterfeit detection efforts, including the use of DNA marking on microelectronics.

Applied DNA Sciences' SigNature® DNA marking program is currently in use by several defense industry suppliers for application on certain categories of electronics deemed to be at high risk for counterfeiting.

The House committee has begun consideration of the Defense Department's fiscal year 2015 budget request, taking particular interest in Department of Defense efforts to combat the intrusion of counterfeit parts into the military supply chain.

The Intelligence, Emerging Threats and Capabilities Subcommittee, one of seven HASC Subcommittees, included legislative language on April 29th directing the Department of Defense to provide the Committee with an assessment of the Defense Department's counterfeit detection efforts, specifically including the use of DNA marking on microelectronics.

The language provides further that the Department of Defense will evaluate expanding anti-counterfeit measures to additional classes of technology deemed high risk, an analysis of counterfeit alerts and problem advisories in the Government Industry Data Exchange Program, and a description of Department of Defense efforts to collaborate with the defense industry on the development of standards associated with counterfeit parts risk mitigation. A copy of the legislative language can be found on page 60 of the following document:
http://docs.house.gov/meetings/AS/AS26/20140430/102128/BILLS-113HR4435ih-U1.pdf

Dr. James A. Hayward, President and CEO of Applied DNA Sciences, commented on the legislative language, “We are proud to contribute to DoD’s efforts to exclude counterfeits from their supply chain. Counterfeit electronics risk cybersecurity, the safety of our war fighters and the reliability of their equipment."

After several procedural steps in Committee, the bill goes the floor of the entire House of Representatives, something that historically has occurred in advance of Memorial Day.

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


Contact